ibuprofen has been researched along with Benign Neoplasms in 34 studies
Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine
Excerpt | Relevance | Reference |
---|---|---|
"Regular aspirin use may decrease cancer risk by reducing chronic inflammation." | 9.20 | Association between Regular Aspirin Use and Circulating Markers of Inflammation: A Study within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. ( Chaturvedi, AK; Hildesheim, A; Katki, HA; Kemp, TJ; Lang Kuhs, KA; Loftfield, E; Pinto, LA; Purdue, MP; Safaeian, M; Shiels, MS; Trabert, B; Wentzensen, N, 2015) |
"Cobrotoxin produces intense analgesia but it has an onset of response of 1-3 h which hampers its clinical use in cancer pain." | 9.12 | Cobrotoxin-containing analgesic compound to treat chronic moderate to severe cancer pain: results from a randomized, double-blind, cross-over study and from an open-label study. ( Bruno, M; Feng, FY; Huang, FL; Paradiso, A; Song, ST; Xie, GR; Xu, JM; Xu, LG; Yang, Y; Zhang, CZ, 2006) |
"To investigate the feasibility, and perform a pilot study, of a randomised clinical trial, investigating whether children experience less pain, fear and/or distress when they receive oral ibuprofen vs placebo before a needle is inserted in a subcutaneously implanted intravenous port." | 5.41 | Ibuprofen in needle procedures in children with cancer-A feasibility and pilot study. ( Hedén, L; Kamsvåg, T; Ljungman, G; von Essen, L, 2021) |
"Regular aspirin use may decrease cancer risk by reducing chronic inflammation." | 5.20 | Association between Regular Aspirin Use and Circulating Markers of Inflammation: A Study within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. ( Chaturvedi, AK; Hildesheim, A; Katki, HA; Kemp, TJ; Lang Kuhs, KA; Loftfield, E; Pinto, LA; Purdue, MP; Safaeian, M; Shiels, MS; Trabert, B; Wentzensen, N, 2015) |
" It is showed that the use of 100 mg of ladasten, 16 mg of ondansetron orally per day and 50 mg of agomelatine per night is more effective in therapy for fatigue/weakness syndrome in incurable cancer patients compared to standard therapy." | 5.20 | [Optimization of pharmacological therapy for weakness syndrome in incurable patients]. ( Glushchenko, VA; Karitsky, AP; Kvashnin, AV; Rozengard, SA; Ryazankina, AA, 2015) |
"Cobrotoxin produces intense analgesia but it has an onset of response of 1-3 h which hampers its clinical use in cancer pain." | 5.12 | Cobrotoxin-containing analgesic compound to treat chronic moderate to severe cancer pain: results from a randomized, double-blind, cross-over study and from an open-label study. ( Bruno, M; Feng, FY; Huang, FL; Paradiso, A; Song, ST; Xie, GR; Xu, JM; Xu, LG; Yang, Y; Zhang, CZ, 2006) |
" In patients with neuropathic pain, topical forms of both capsaicin and lidocaine have been shown to be useful in the treatment of postherpetic neuralgia and diabetic peripheral neuropathic pain." | 4.89 | Topical therapies in the management of chronic pain. ( Galluzzi, KE; Stanos, SP, 2013) |
" In addition, characterization of the UGT1A locus and genetic studies directed at understanding the role of bilirubin glucuronidation and the biochemical basis of the clinical symptoms found in unconjugated hyperbilirubinemia have uncovered the structural gene polymorphisms associated with Crigler-Najjar's and Gilbert's syndrome." | 4.80 | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. ( Strassburg, CP; Tukey, RH, 2000) |
"Ibuprofen is a classical nonsteroidal anti-inflammatory drug (NSAID) highly prescribed to reduce acute pain and inflammation under an array of conditions, including rheumatoid arthritis, osteoarthritis, dysmenorrhea, and gout." | 4.02 | Ibuprofen-based advanced therapeutics: breaking the inflammatory link in cancer, neurodegeneration, and diseases. ( Amanullah, A; Dhiman, R; Joshi, V; Mishra, A; Poluri, KM; Prajapati, VK; Upadhyay, A, 2021) |
"Pemetrexed (500 mg/m(2)) with vitamin supplementation is well tolerated and requires no dosage adjustment when coadministered with aspirin (in patients with CrCl > or =60 mL/min) or ibuprofen (in patients with CrCl > or =80 mL/min)." | 2.72 | Two drug interaction studies evaluating the pharmacokinetics and toxicity of pemetrexed when coadministered with aspirin or Ibuprofen in patients with advanced cancer. ( Baker, SD; Battiato, L; Chaudhary, AK; Chaudhuri, T; Cleverly, A; Fife, K; Krull, JH; Latz, JE; Mita, AC; Murry, DJ; Rowinsky, EK; Sandler, A; Sweeney, CJ; Takimoto, CH, 2006) |
"Cancer cachexia is a devastating syndrome of advanced malignancy which negatively impacts on patients' morbidity, mortality and quality of life." | 2.49 | Non-steroidal anti-inflammatory drugs for the treatment of cancer cachexia: a systematic review. ( Cantwell, MM; Hughes, CM; Murray, LJ; Parsons, C; Reid, J, 2013) |
"The biological role of AMACR in cancer is complex, linking lipid metabolism with nuclear receptor (e." | 2.49 | α-Methylacyl-CoA racemase (AMACR): metabolic enzyme, drug metabolizer and cancer marker P504S. ( Lee, GL; Lloyd, MD; Threadgill, MD; Wood, PJ; Woodman, TJ; Yevglevskis, M, 2013) |
"The "cimetidine + ibuprofen"-treated mice displayed greater T-bet expression than the un-treated mice (P<0." | 1.72 | Cimetidine and Ibuprofen Modulate T Cell Responses in a Mouse Model of Breast Cancer. ( Hassan, ZM; Jafarzadeh, A; Nemati, M; Oladpour, O; Rezayati, MT; Taghipour, F; Taghipour, Z, 2022) |
"The anticancer potential of ibuprofen has created a broad interest to explore the clinical benefits of ibuprofen in cancer therapy." | 1.56 | Ibuprofen mediates histone modification to diminish cancer cell stemness properties via a COX2-dependent manner. ( Bao, Y; Du, R; Gao, W; Li, J; Luo, N; Shen, W; Wang, J; Yang, W; Zhang, X, 2020) |
"Celecoxib and ibuprofen treatment reversed the reduced production of glucose, pyruvate, lactate and urea from alanine as well as the reduced production of glucose from pyruvate and lactate in perfused liver from tumor-bearing rats." | 1.42 | Celecoxib and Ibuprofen Restore the ATP Content and the Gluconeogenesis Activity in the Liver of Walker-256 Tumor-Bearing Rats. ( Curi, R; de Morais, H; de Souza, CO; de Souza, HM; Hirabara, SM; Kurauti, MA; Rosa Neto, JC; Silva, Fde F, 2015) |
"NSAIDs' benefit on cancer risk was therefore limited to specific sites and not evident when total cancer risk was examined." | 1.40 | Non-steroidal anti-inflammatory drugs and cancer risk in women: results from the Women's Health Initiative. ( Allison, MA; Baik, CS; Brasky, TM; Lane, DS; Liu, J; Manson, JE; Peters, U; Potter, JD; Tang, JY; Vitolins, MZ; Wactawski-Wende, J; Walter, RB; White, E, 2014) |
"To develop effective strategies in cancer chemoprevention, an increased understanding of endogenous biochemical mediators that block metastatic processes is critically needed." | 1.37 | Cellular diamine levels in cancer chemoprevention: modulation by ibuprofen and membrane plasmalogens. ( Goodenowe, DB; Khan, MA; Smith, T; Wood, PL, 2011) |
"and compound 7c exhibit good anticancer activity against ovary (IGR-OV-1), breast (MCF-7) and CNS(SF-295) human cancer cell lines." | 1.36 | Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives. ( Agrawal, SK; Rani, R; Roy, P; Saxena, AK; Singh, J; Sondhi, SM, 2010) |
"Pretreatment with ibuprofen (1,600 mg) abrogated these side effects, allowing further escalation of LPS doses up to 10 ng/kg of body weight." | 1.28 | Biological response to intravenously administered endotoxin in patients with advanced cancer. ( Andreesen, R; Engelhardt, R; Galanos, C; Mackensen, A, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.94) | 18.7374 |
1990's | 2 (5.88) | 18.2507 |
2000's | 6 (17.65) | 29.6817 |
2010's | 18 (52.94) | 24.3611 |
2020's | 7 (20.59) | 2.80 |
Authors | Studies |
---|---|
Tukey, RH | 1 |
Strassburg, CP | 1 |
Diamandis, P | 1 |
Wildenhain, J | 1 |
Clarke, ID | 1 |
Sacher, AG | 1 |
Graham, J | 1 |
Bellows, DS | 1 |
Ling, EK | 1 |
Ward, RJ | 1 |
Jamieson, LG | 1 |
Tyers, M | 1 |
Dirks, PB | 1 |
Sondhi, SM | 1 |
Rani, R | 1 |
Singh, J | 1 |
Roy, P | 1 |
Agrawal, SK | 1 |
Saxena, AK | 1 |
Kang, HB | 2 |
Rim, HK | 1 |
Park, JY | 1 |
Choi, HW | 1 |
Choi, DL | 1 |
Seo, JH | 2 |
Chung, KS | 1 |
Huh, G | 1 |
Kim, J | 1 |
Choo, DJ | 1 |
Lee, KT | 1 |
Lee, JY | 1 |
Bansal, Y | 1 |
Kaur, M | 1 |
Silakari, O | 1 |
Lin, R | 1 |
Elf, S | 1 |
Shan, C | 1 |
Ji, Q | 1 |
Zhou, L | 1 |
Hitosugi, T | 1 |
Zhang, L | 1 |
Zhang, S | 1 |
Xie, J | 1 |
Tucker, M | 1 |
Gu, TL | 1 |
Sudderth, J | 1 |
Jiang, L | 1 |
Mitsche, M | 1 |
DeBerardinis, RJ | 1 |
Wu, S | 1 |
Li, Y | 1 |
Mao, H | 1 |
Chen, PR | 1 |
Wang, D | 1 |
Chen, GZ | 1 |
Hurwitz, SJ | 1 |
Lonial, S | 1 |
Arellano, ML | 1 |
Khoury, HJ | 1 |
Khuri, FR | 1 |
Lee, BH | 1 |
Lei, Q | 1 |
Brat, DJ | 1 |
Ye, K | 1 |
Boggon, TJ | 1 |
He, C | 1 |
Kang, S | 1 |
Fan, J | 1 |
Chen, J | 1 |
Ali, EMH | 1 |
Abdel-Maksoud, MS | 1 |
Oh, CH | 1 |
Brandt, F | 1 |
Ullrich, M | 1 |
Laube, M | 1 |
Kopka, K | 1 |
Bachmann, M | 1 |
Löser, R | 1 |
Pietzsch, J | 1 |
Pietzsch, HJ | 1 |
van den Hoff, J | 1 |
Wodtke, R | 1 |
Bajpai, A | 1 |
Chhabria, D | 1 |
Mishra, T | 1 |
Kirubakaran, S | 1 |
Basu, S | 1 |
Oladpour, O | 1 |
Taghipour, F | 1 |
Hassan, ZM | 1 |
Rezayati, MT | 1 |
Nemati, M | 1 |
Taghipour, Z | 1 |
Jafarzadeh, A | 1 |
Raaijmakers, TK | 1 |
van den Bijgaart, RJE | 1 |
Scheffer, GJ | 1 |
Ansems, M | 1 |
Adema, GJ | 1 |
Pereira, CV | 1 |
Silva, JM | 1 |
Rodrigues, L | 1 |
Reis, RL | 1 |
Paiva, A | 1 |
Duarte, ARC | 1 |
Matias, A | 1 |
Shen, W | 1 |
Zhang, X | 1 |
Du, R | 1 |
Gao, W | 1 |
Wang, J | 1 |
Bao, Y | 1 |
Yang, W | 1 |
Luo, N | 1 |
Li, J | 1 |
Kamsvåg, T | 1 |
Hedén, L | 1 |
von Essen, L | 1 |
Ljungman, G | 1 |
Upadhyay, A | 1 |
Amanullah, A | 1 |
Joshi, V | 1 |
Dhiman, R | 1 |
Prajapati, VK | 1 |
Poluri, KM | 1 |
Mishra, A | 1 |
Zhao, L | 1 |
Shen, G | 1 |
Ma, G | 1 |
Yan, X | 1 |
Stanos, SP | 1 |
Galluzzi, KE | 1 |
Fountain, EM | 1 |
Dhurandhar, A | 1 |
Brasky, TM | 2 |
Liu, J | 1 |
White, E | 2 |
Peters, U | 2 |
Potter, JD | 2 |
Walter, RB | 1 |
Baik, CS | 1 |
Lane, DS | 1 |
Manson, JE | 1 |
Vitolins, MZ | 1 |
Allison, MA | 1 |
Tang, JY | 1 |
Wactawski-Wende, J | 1 |
Reddy, A | 1 |
Yennurajalingam, S | 1 |
Desai, H | 1 |
Reddy, S | 1 |
de la Cruz, M | 1 |
Wu, J | 1 |
Liu, D | 1 |
Rodriguez, EM | 1 |
Waletich, J | 1 |
Shin, SH | 1 |
Gayle, V | 1 |
Patel, P | 1 |
Dalal, S | 1 |
Vidal, M | 1 |
Tanco, K | 1 |
Arthur, J | 1 |
Tallie, K | 1 |
Williams, J | 1 |
Silvestre, J | 1 |
Bruera, E | 1 |
Lang Kuhs, KA | 1 |
Hildesheim, A | 1 |
Trabert, B | 1 |
Kemp, TJ | 1 |
Purdue, MP | 1 |
Wentzensen, N | 1 |
Katki, HA | 1 |
Pinto, LA | 1 |
Loftfield, E | 1 |
Safaeian, M | 1 |
Chaturvedi, AK | 1 |
Shiels, MS | 1 |
Ryazankina, AA | 1 |
Rozengard, SA | 1 |
Glushchenko, VA | 1 |
Karitsky, AP | 1 |
Kvashnin, AV | 1 |
de Souza, CO | 1 |
Kurauti, MA | 1 |
Silva, Fde F | 1 |
de Morais, H | 1 |
Curi, R | 2 |
Hirabara, SM | 1 |
Rosa Neto, JC | 1 |
de Souza, HM | 1 |
Wood, PL | 1 |
Khan, MA | 1 |
Smith, T | 1 |
Goodenowe, DB | 1 |
Kristal, AR | 1 |
Patterson, RE | 1 |
Asgari, MM | 1 |
Thornquist, MD | 1 |
Reid, J | 1 |
Hughes, CM | 1 |
Murray, LJ | 1 |
Parsons, C | 1 |
Cantwell, MM | 1 |
Lloyd, MD | 1 |
Yevglevskis, M | 1 |
Lee, GL | 1 |
Wood, PJ | 1 |
Threadgill, MD | 1 |
Woodman, TJ | 1 |
Harris, RE | 1 |
Beebe-Donk, J | 1 |
Doss, H | 1 |
Burr Doss, D | 1 |
Acharya, MR | 1 |
Sparreboom, A | 1 |
Sausville, EA | 1 |
Conley, BA | 1 |
Doroshow, JH | 1 |
Venitz, J | 1 |
Figg, WD | 1 |
Sweeney, CJ | 1 |
Takimoto, CH | 1 |
Latz, JE | 1 |
Baker, SD | 1 |
Murry, DJ | 1 |
Krull, JH | 1 |
Fife, K | 1 |
Battiato, L | 1 |
Cleverly, A | 1 |
Chaudhary, AK | 1 |
Chaudhuri, T | 1 |
Sandler, A | 1 |
Mita, AC | 1 |
Rowinsky, EK | 1 |
Xu, JM | 1 |
Song, ST | 1 |
Feng, FY | 1 |
Huang, FL | 1 |
Yang, Y | 1 |
Xie, GR | 1 |
Xu, LG | 1 |
Zhang, CZ | 1 |
Bruno, M | 1 |
Paradiso, A | 1 |
Ferrer-Brechner, T | 1 |
Ganz, P | 1 |
de Bittencourt Júnior, PI | 1 |
Yano, MM | 1 |
Hirata, MH | 1 |
Williams, JF | 1 |
Engelhardt, R | 1 |
Mackensen, A | 1 |
Galanos, C | 1 |
Andreesen, R | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Trial Evaluating multimOdal toPical Cream In CompArison to pLacebo (TOPICAL)[NCT03199417] | Phase 2/Phase 3 | 50 participants (Actual) | Interventional | 2017-05-01 | Terminated (stopped due to Terminated prematurely due to feasibility issues with rate of recruitment) | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
8 reviews available for ibuprofen and Benign Neoplasms
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; | 2000 |
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; | 2015 |
Thieno[2,3-d]pyrimidine as a promising scaffold in medicinal chemistry: Recent advances.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Chemistry, Ph | 2019 |
Engineering and delivery of nanocolloids of hydrophobic drugs.
Topics: Antineoplastic Agents; Chemical Engineering; Colloids; Drug Compounding; Drug Delivery Systems; Drug | 2017 |
Topical therapies in the management of chronic pain.
Topics: Administration, Cutaneous; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Capsaicin; C | 2013 |
Non-steroidal anti-inflammatory drugs for the treatment of cancer cachexia: a systematic review.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Cachexia; Celecoxib; Cyclooxygenase 2 I | 2013 |
α-Methylacyl-CoA racemase (AMACR): metabolic enzyme, drug metabolizer and cancer marker P504S.
Topics: Animals; Biomarkers, Tumor; Drug Design; Humans; Ibuprofen; Neoplasms; Pharmaceutical Preparations; | 2013 |
Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review).
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Case-Control Stu | 2005 |
7 trials available for ibuprofen and Benign Neoplasms
Article | Year |
---|---|
Ibuprofen in needle procedures in children with cancer-A feasibility and pilot study.
Topics: Child; Feasibility Studies; Humans; Ibuprofen; Neoplasms; Pain; Pilot Projects | 2021 |
The opioid rotation ratio of hydrocodone to strong opioids in cancer patients.
Topics: Aged; Analgesics, Opioid; Female; Humans; Hydrocodone; Ibuprofen; Linear Models; Male; Middle Aged; | 2014 |
Association between Regular Aspirin Use and Circulating Markers of Inflammation: A Study within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biomarkers; Colorectal Neoplasms; Early Dete | 2015 |
[Optimization of pharmacological therapy for weakness syndrome in incurable patients].
Topics: Acetamides; Adamantane; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Ant | 2015 |
Two drug interaction studies evaluating the pharmacokinetics and toxicity of pemetrexed when coadministered with aspirin or Ibuprofen in patients with advanced cancer.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineopla | 2006 |
Cobrotoxin-containing analgesic compound to treat chronic moderate to severe cancer pain: results from a randomized, double-blind, cross-over study and from an open-label study.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Cobra Neurotoxin Proteins; Cross-Over Studies; Double-Bl | 2006 |
Combination therapy with ibuprofen and methadone for chronic cancer pain.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Emotions; Fem | 1984 |
19 other studies available for ibuprofen and Benign Neoplasms
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutic | 2007 |
Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Benzimidazoles; Breast Neoplasms; Cell Line, Tumor; | 2010 |
In vivo evaluation of oral anti-tumoral effect of 3,4-dihydroquinazoline derivative on solid tumor.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Res | 2012 |
Benzimidazole--ibuprofen/mesalamine conjugates: potential candidates for multifactorial diseases.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Benzimidazoles; Edema; Ibup | 2015 |
"Clickable" Albumin Binders for Modulating the Tumor Uptake of Targeted Radiopharmaceuticals.
Topics: Albumins; Animals; Copper Radioisotopes; Lysine; Mice; Neoplasms; Positron-Emission Tomography; Prot | 2022 |
Small molecule NSAID derivatives for impairing powerhouse in cancer cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Ibuprofen; Indomethacin; Mitochondria; Neoplasms | 2022 |
Cimetidine and Ibuprofen Modulate T Cell Responses in a Mouse Model of Breast Cancer.
Topics: Animals; Cimetidine; Disease Models, Animal; Forkhead Transcription Factors; Ibuprofen; Mice; Mice, | 2022 |
NSAIDs affect dendritic cell cytokine production.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens, Neoplasm; CD8-Positive T-Lymphocytes; Ce | 2022 |
Unveil the Anticancer Potential of Limomene Based Therapeutic Deep Eutectic Solvents.
Topics: Antineoplastic Agents; Caco-2 Cells; Cell Proliferation; Cell Survival; Decanoic Acids; Drug Compoun | 2019 |
Ibuprofen mediates histone modification to diminish cancer cell stemness properties via a COX2-dependent manner.
Topics: A549 Cells; Acetylation; Animals; Cell Line, Tumor; Cyclooxygenase 2; Drug Resistance, Neoplasm; Fem | 2020 |
Ibuprofen-based advanced therapeutics: breaking the inflammatory link in cancer, neurodegeneration, and diseases.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Female; Humans; Ibuprofen; Neoplasms | 2021 |
Neuro-Behçet's disease: an unusual cause of headache.
Topics: Anti-Inflammatory Agents; Behcet Syndrome; Diagnosis, Differential; Female; Gait Disorders, Neurolog | 2014 |
Non-steroidal anti-inflammatory drugs and cancer risk in women: results from the Women's Health Initiative.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Female; Humans; Ibu | 2014 |
Celecoxib and Ibuprofen Restore the ATP Content and the Gluconeogenesis Activity in the Liver of Walker-256 Tumor-Bearing Rats.
Topics: Adenosine Triphosphate; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Gluconeogenesis | 2015 |
Cellular diamine levels in cancer chemoprevention: modulation by ibuprofen and membrane plasmalogens.
Topics: Amino Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cadaverine; Cell Membrane; CHO Cells; | 2011 |
Non-steroidal anti-inflammatory drugs and cancer incidence by sex in the VITamins And Lifestyle (VITAL) cohort.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Colorectal Neoplasms; Confidence Intervals; Female; H | 2012 |
Interspecies differences in plasma protein binding of MS-275, a novel histone deacetylase inhibitor.
Topics: Animals; Area Under Curve; Benzamides; Binding, Competitive; Blood Proteins; Dogs; Glycoproteins; Ha | 2006 |
Evidence that prostaglandins modulate lipogenesis in cultured lymphocytes--a comparison with its effect on macrophages and tumour cells.
Topics: Acetates; Animals; Arachidonic Acid; Carbon Radioisotopes; Cells, Cultured; Concanavalin A; DNA; DNA | 1994 |
Biological response to intravenously administered endotoxin in patients with advanced cancer.
Topics: Adult; Aged; C-Reactive Protein; Female; Hematologic Tests; Humans; Ibuprofen; Injections, Intraveno | 1990 |